SCHEMBL1896186

SCHEMBL1896186

O=C(O)c1ccc(N2CCNCC2)nc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 1/20 0.53
▸ HPGDS O60760 1/20 0.51
▸ HDAC2 Q92769 6/20 0.49
▸ HDAC3 O15379 4/20 0.49
▸ SMO Q99835 1/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ ITGA2B P08514 1/20 0.48
▸ OGA O60502 1/20 0.48
▸ NPC1 O15118 1/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ LMNA P02545 1/20 0.48
▸ HDAC1 Q13547 4/20 0.47
▸ HDAC10 Q969S8 1/20 0.47
▸ HDAC6 Q9UBN7 1/20 0.47
▸ PLD1 Q13393 1/20 0.47
▸ HRH3 Q9Y5N1 1/20 0.47
▸ USP2 O75604 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7550033 0.98 KCNH2 (0.52) KCNH2HPGDSHDAC2HDAC3SMO
Hydrochloric Acid SCHEMBL31552815 0.98 KCNH2 (0.52) KCNH2HPGDSHDAC2HDAC3SMO
SCHEMBL7547417 0.98 KCNH2 (0.52) KCNH2HPGDSHDAC2HDAC3SMO
SCHEMBL5202077 0.94 KCNH2 (0.49) KCNH2HPGDSHDAC2HDAC3SMO
SCHEMBL29524173 0.86 PARP1 (0.53) KCNH2HPGDSHDAC2HDAC3SMO
SCHEMBL4935859 0.86 MAPT (0.51) KCNH2HPGDSHDAC2HDAC3ALDH1A1
SCHEMBL2706925 0.86 PARP1 (0.53) KCNH2HPGDSHDAC2HDAC3SMO
SCHEMBL1989630 0.85 UBE2T (0.63) HPGDSSMOALDH1A1OGANPC1
SCHEMBL29784322 0.85 UBE2T (0.63) HPGDSSMOALDH1A1OGANPC1
SCHEMBL31352228 0.85 UBE2T (0.58) HPGDSSMOALDH1A1OGANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2350311-B1 DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS MADRIGAL PHARMACEUTICALS INC (US) 2013-12-25 — — EP claimed
US-8324385-B2 Diacylglycerol acyltransferase inhibitors MADRIGAL PHARMACEUTICALS, INC. (US) 2012-12-04 — — US claimed
EP-2350311-A1 DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS Via Pharmaceuticals, Inc. (US) 2011-08-03 — — EP claimed
WO-2010056506-A1 DIACYLGLYCEROL ACLYTRANSFERASE INHIBITORS VIA PHARMACEUTICALS, INC. (US) 2010-05-20 — — WO claimed
US-20100113782-A1 Diacylglycerol Acyltransferase Inhibitors MADRIGAL PHARMACEUTICALS, INC. 2010-05-06 — — US claimed
EP-0885886-B1 PYRIDINECARBOXAMIDE DERIVATIVES NISSHIN SEIFUN GROUP INC (JP) 2002-05-29 — — EP claimed
EP-0882716-B1 PYRIDINECARBOXAMIDE DERIVATIVES NISSHIN PHARMA INC (JP) 2002-04-10 — — EP claimed
US-6046201-A Pyridinecarboxamide derivatives NISSHIN FLOUR MILLING CO., LTD. (JP) 2000-04-04 — — US claimed
US-5972943-A N-(NITRIC ACID,C14-18 ALKYL ESTER)-6-(1-(OPTIONALLY 4-SUBSTITUTED PIPERAZINYL)) PYRIDINE-3-CARBOXAMIDES; METHOD OF SYNTHESIS; ADMINISTERING TO TREAT CEREBRAL EDEMA; NO HYPOTENSIVE SIDE EFFECT NISSHIN FLOUR MILLING CO., LTD. (JP) 1999-10-26 — — US claimed
EP-0885886-A1 NOVEL PYRIDINECARBOXAMIDE DERIVATIVES Nisshin Flour Milling Co., Ltd. (JP) 1998-12-23 — — EP claimed
EP-0882716-A1 PYRIDINECARBOXAMIDE DERIVATIVES Nisshin Flour Milling Co., Ltd. (JP) 1998-12-09 — — EP claimed
US-20240025923-A1 BIFUNCTIONAL DEGRADERS OF HEMATOPOIETIC PROGENITOR KINASE AND THERAPEUTIC USES THEREOF NURIX THERAPEUTICS INC (US) 2024-01-25 — — US disclosed
US-11739101-B2 Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof NURIX THERAPEUTICS, INC. (US) 2023-08-29 — — US disclosed
CN-113248427-B Sulfonyl nicotinic acid derivative, amido nicotinic acid derivative, preparation method and application thereof 苏州大学 2023-05-02 — — CN disclosed
EP-4146660-A1 BIFUNCTIONAL DEGRADERS OF HEMATOPOIETIC PROGENITOR KINASE AND THERAPEUTIC USES THEREOF Nurix Therapeutics, Inc. (US) 2023-03-15 — — EP disclosed
EP-0885886-A1 NOVEL PYRIDINECARBOXAMIDE DERIVATIVES Nisshin Flour Milling Co., Ltd. (JP) 1998-12-23 — — EP disclosed
EP-0882716-A1 PYRIDINECARBOXAMIDE DERIVATIVES Nisshin Flour Milling Co., Ltd. (JP) 1998-12-09 — — EP disclosed
EP-0385351-B1 Nicotinic acid derivatives and pharmaceutical compositions comprising same NISSHIN FLOUR MILLING CO (JP) 1995-01-11 — — EP disclosed
US-5025012-A Cardiovascular disorders; antiischemic agents NISSHIN FLOUR MILLING CO., LTD. (JP) 1991-06-18 — — US disclosed
EP-0385351-A1 Nicotinic acid derivatives and pharmaceutical compositions comprising same NISSHIN FLOUR MILLING CO., LTD. (JP) 1990-09-05 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11739101-B2 Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof TTK, HIPK1, HIPK2 KCNH2 4828/4885HPGDS 276/4885HDAC2 1769/4885
US-20100113782-A1 Diacylglycerol Acyltransferase Inhibitors DGAT2, DGAT1, MOGAT2 KCNH2 1879/4885HPGDS 573/4885HDAC2 1730/4885
US-20240025923-A1 BIFUNCTIONAL DEGRADERS OF HEMATOPOIETIC PROGENITOR KINASE AND THERAPEUTIC USES THEREOF TTK, HIPK1, HIPK2 KCNH2 4828/4885HPGDS 276/4885HDAC2 1769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback